Dipal Doshi
No shares they bought or sold themselves in the last 12 months. Their newest Form 4, for Sep 2: tax withholding (8,724 TRDA shares).
We do the work for you. Every stock is scored and ranked, every 15 seconds while the market is open. Here it's 15 minutes behind. Pro members see it live.
Every trade Dipal Doshi reported
None in the last 12 months, as filed.
We do the work for you. Every stock is scored and ranked, every 15 seconds while the market is open. Here it's 15 minutes behind. Pro members see it live.
Dipal Doshi's companies
| Stock | Trades | Quality Score |
|---|---|---|
| 0 | ||
| 0 |
Alerts for Dipal Doshi
Use this page
How to cite
Breakaway, Dipal Doshi: CEO at Entrada Therapeutics (TRDA), Sep 2, 2026, getbreakaway.com/insiders/dipal-doshi
Journalists: email support@getbreakaway.com for the data behind this page.